Agilent Technologies A boosts its LSAG segment with the launch of the Agilent InfinityLab Liquid Chromatography (LC) Series portfolio, comprising the 1290 Infinity III LC, 1260 Infinity III Prime LC and 1260 Infinity III LC systems.

The new Agilent InfinityLab Assist Technology is being used for the first time in these High Performance Liquid Chromatography systems, providing enhanced system assistance.

These systems have a significant impact on task automation, connectivity, predictive feedback and error reduction.

Agilent InfinityLab LC Series’ built-in sample tracking feature, which uses barcoding and camera technologies, ensures that sample mix-ups are avoided, providing users with maximum efficiency.

Agilent Technologies, Inc. Price and Consensus

Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote

LSAG Portfolio Expansion to Aid Agilent’s Prospects

Agilent’s latest product offerings in the LSAG segment are expected to drive top-line growth.

A’s introduction of an advanced gas chromatography/mass spectrometry (GC/MS) column technology product, namely J&W 5Q GC/MS Columns, to expand its LSAG segment is a noteworthy development.

The new GC/MS columns are designed to expedite GC/MS workflows and boost system performance in challenging conditions.

A recently launched Biopharma CDx Services Lab (BCSL) to facilitate precision medicine. The BCSL and Agilent’s assay development model will support drug development from early clinical studies through regulatory approval with efficient, flexible and streamlined diagnostic development.

Strategic Acquisitions to Boost A’s Prospects

Agilent recently inked an agreement with Sangon Biotech to leverage its comprehensive product portfolio and full workflow solutions to strengthen Sangon’s capacity for testing and analysis to serve its customers better.

The recent acquisition of Canada’s BIOVECTRA is a major development by A. With this transaction, Agilent can widen its portfolio of contract development and manufacturing organization services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.

Agilent’s acquisition of California-based Sigsense, a start-up that uses artificial intelligence and power monitoring to help customers optimize their lab operations might be a plus in the near term.

Agilent Suffers From Persistent Headwinds

Despite accretive acquisitions and product innovations, macroeconomic uncertainties, including regulatory concerns in China and slow capital spending by customers are major concerns.

A’s shares have lost 1.6% year to date (YTD), underperforming the broader Zacks Computer and Technology sector’s return of 26.9%. It also underperformed its industry and peers, including Itron ITRI, Teradyne TER and Fortive FTV.

Over the same time frame, shares of Itron, Teradyne and Fortive have gained 36.6%, 16.1% and 4.8%, respectively. The industry appreciated 4.1% YTD.